After the Rothman Institute in Philadelphia instituted new protocols for pain control, they have decreased opioid prescribing, consumption and refills. According to a report in Orthopedics Today, these new protocols have been in place for a few years now with good results. Multimodal pain control plays a role, and in some cases, includes cannabinoids. “For pain management postoperatively, Ari C. Greis, DO, director of the medical cannabis department at Rothman Orthopaedic Institute, noted they have begun to recognize when to transition patients onto non-opioid medications, including cannabis, which was legalized in Pennsylvania in 2018.” Full story.